Evidence map›Paper›PMID 32403433›Full record

ArticleInternational journal of molecular sciences2020

Xin Meng, Jinrui Zhang, Hao Wu, Dahai Yu, Xuexun Fang

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Biomolecules · 2026
    Review
  4. Review
  5. Review
  6. Review
  7. Mechanism and application ofFrontiers in cellular and infection microbiology · 2026
    Review
  8. Review
  9. International journal of molecular sciences · 2025
    Review
  10. Review
  11. Current oncology (Toronto, Ont.) · 2025
    Review
  12. The Biology ofAnnual review of microbiology · 2025
    Review
  13. Review
  14. Review
  15. The role ofiMetaOmics · 2025
    Article
  16. Article
  17. Article
  18. Big lessons from the littleFrontiers in immunology · 2025
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Xin MengKey Laboratory for Molecular Enzymology and Engineering of Ministry of Education, College of Life Science, Jilin University, Changchun 130012, China.ORCID 0000-0003-0318-8363
Jinrui ZhangKey Laboratory for Molecular Enzymology and Engineering of Ministry of Education, College of Life Science, Jilin University, Changchun 130012, China.
Hao WuVascular Biology Program, Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Dahai YuKey Laboratory for Molecular Enzymology and Engineering of Ministry of Education, College of Life Science, Jilin University, Changchun 130012, China.
Xuexun FangKey Laboratory for Molecular Enzymology and Engineering of Ministry of Education, College of Life Science, Jilin University, Changchun 130012, China.
Jilin University · CNBoston Children's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mucin2 (Muc2) is the main component of the intestinal mucosal layer and is highly expressed in mucous colorectal cancer. Previous studies conducted by our lab found that the recombinant protein Amuc_1434 (expressed in

Indexed as

AkkermansiaApoptosisAspartic Acid ProteasesBacterial ProteinsCell Line, TumorCell SurvivalColorectal NeoplasmsG1 Phase Cell Cycle CheckpointsHumansMembrane Potential, MitochondrialRecombinant ProteinsResting Phase, Cell CycleSignal TransductionTNF-Related Apoptosis-Inducing LigandUp-RegulationAspartic Acid ProteasesBacterial ProteinsRecombinant ProteinsTNF-Related Apoptosis-Inducing LigandAmuc_1434*apoptosiscolorectal cancer cellsproliferationTRAIL

Identifiers

PMID32403433
PMCPMC7246985
OpenAlexW3021147684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.